Spectrophotometry and pharmaceutical PAT/RTRT: Practical challenges and regulatory landscape from development to product lifecycle

نویسندگان

چکیده

European Pharmacopoeia includes dedicated chapters for Raman, NIR and Chemometrics, as well there is a lot of Academia research on the matter. Despite that, word innovation often associated to such tools still slow implementation at industry. The paper outcome Associazione Farmaceutici dell’Industria (AFI) Study Group Process Innovation Product Lifecycle; aim describe some case studies referring practical approaches in pharmaceutical industry, order depict challenges opportunities spectroscopic techniques. Case include: feasibility pre-screening evaluations, chemometric model development approaches, way method maintenance during commercial manufacturing, existing equipment sterile processes. refer oral solid products, liquid products Active Pharmaceutical Ingradient (API) manufacturing. There are already successful robust applications industry technology mature: this strong applied performed production departments. It necessary acknowledge efforts done by Research strengthening cooperation with Academia, so that advantage process might reach patients fastest way.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Product Lifecycle Management Challenges in

In today’s world, products are designed, manufactured, distributed across multiple countries and boundaries. The implementation of Product Lifecycle Management (PLM) in a global marketplace faces new challenges in structurally different, yet closely interconnected economies. This paper first details the challenges on language differences, culture gaps, multiple standards and customization in th...

متن کامل

New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

متن کامل

New Product Development in the Pharmaceutical Industry: Evidence from Iran

In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...

متن کامل

Transition to total service solution: Managing challenges in service development to expand a product lifecycle

Total service solutions may reduce 30-40% of the total product lifecycle cost for a customer. The installed base of capital goods frequently exceeds the annual flow of new products by 10 to 100 times which indicates that total service solutions, also late in long lifecycles have a huge potential for providers, customers and society. The paper identifies 23 possible challenges when a provider of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: International Journal of Pharmaceutics

سال: 2021

ISSN: ['0378-5173', '1873-3476']

DOI: https://doi.org/10.1016/j.ijpharm.2021.120551